Skip to main content
Equibles

Forefront Analytics, LLC

Position in GERN — Geron Corp

CIK 1696802 WEST CONSHOHOCKEN, PA
Back to GERN Full portfolio

Position in GERN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$113,637
+$31,501 QoQ
Shares Held
88,779
+61.1% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#129
of 260 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GERN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Forefront Analytics, LLC holds $1,763,485 across 9 Biotechnology names. GERN ranks #5 (6.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 5,091 $577,115
2 LEGN
Legend Biotech Corp
 10,568 $305,203
3 REGN
Regeneron Pharmaceuticals, Inc.
 415 $258,769
4 ZURA
Zura Bio Ltd
 26,968 $159,111
5 GERN
Geron Corp
This page 		88,779 $113,637
6 CTMX
CytomX Therapeutics, Inc.
 25,033 $93,873
7 BCYC
Bicycle Therapeutics PLC
 21,822 $92,525
8 NKTX
Nkarta, Inc.
 28,955 $81,942

All Filings in GERN

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $113,637 88,779
2026-03-31 $82,136 55,125
2025-12-31 $67,742 51,320
2025-09-30 $71,593 52,258
2025-06-30 $49,605 35,181
2025-03-31 $100,126 62,973
2024-12-31 $67,341 19,023
2024-09-30 $83,949 18,491
2024-06-30 $84,401 19,906
2024-03-31 $58,990 17,876
2023-12-31 $59,746 28,316
2023-09-30 $61,725 29,116
2023-06-30 $47,800 14,891
2023-03-31 $59,852 27,582
2022-12-31 $65,090 26,897
2022-09-30 $41,150 17,586
2022-06-30 $53,840 34,736
2022-03-31 $117,824 86,636
2021-12-31 $103,133 84,536
2021-09-30 $112,799 82,336
2021-06-30 $107,844 76,486
2021-03-31 $112,018 70,898
2020-12-31 $95,678 60,175
2020-09-30 $111,237 63,930